IDNAvsSPMD
iShares Genomics Immunology and Healthcare ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | SPMD | |
|---|---|---|
| Expense ratio | 0.47% | 0.030% |
| Assets | $317M | $18.4B |
| Net flow, 1 month | +$49M | +$184M |
| Net flow, 1 year | +$106M | +$2B |
| Return, YTD | +56.1% | +11.9% |
| Return, 1 year | +66.5% | +12.3% |
| Avg daily volume | 195K | 1.7M |
| Holdings | 63 | 401 |
| Listed | Jun 11, 2019 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS